Works matching IS 03618609 AND DT 2024 AND VI 99 AND IP 2

Results: 31
    1
    2
    3

    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
    By:
    • Karrar, Omer;
    • Abdelmagid, Maymona;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant;
    • Foran, James
    Publication type:
    Article
    4
    5
    6

    Long‐term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open‐label extension study following a phase 3 placebo‐controlled, double‐blind, parallel‐group study.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E55, doi. 10.1002/ajh.27176
    By:
    • Kuwana, Masataka;
    • Ito, Tomoki;
    • Kowata, Shugo;
    • Hatta, Yoshihiro;
    • Fujimaki, Katsumichi;
    • Naito, Kensuke;
    • Kurahashi, Shingo;
    • Kagoo, Toshiya;
    • Tanimoto, Kazuki;
    • Saotome, So;
    • Tomiyama, Yoshiaki
    Publication type:
    Article
    7

    Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 263, doi. 10.1002/ajh.27174
    By:
    • Konuma, Takaaki;
    • Harada, Kaito;
    • Shinohara, Akihito;
    • Uchida, Naoyuki;
    • Shingai, Naoki;
    • Ito, Ayumu;
    • Ozawa, Yukiyasu;
    • Tanaka, Masatsugu;
    • Sawa, Masashi;
    • Onizuka, Makoto;
    • Katayama, Yuta;
    • Hiramoto, Nobuhiro;
    • Nakano, Nobuaki;
    • Kimura, Takafumi;
    • Kanda, Yoshinobu;
    • Fukuda, Takahiro;
    • Atsuta, Yoshiko;
    • Nakasone, Hideki;
    • Kanda, Junya
    Publication type:
    Article
    8

    Comparison of fludarabine‐based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry‐based study.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 236, doi. 10.1002/ajh.27172
    By:
    • Kurita, Naoki;
    • Imahashi, Nobuhiko;
    • Chiba, Shigeru;
    • Tanaka, Masatsugu;
    • Kobayashi, Hikaru;
    • Uchida, Naoyuki;
    • Kuriyama, Takuro;
    • Anzai, Naoyuki;
    • Nawa, Yuichiro;
    • Nakano, Nobuaki;
    • Ara, Takahide;
    • Onizuka, Makoto;
    • Katsuoka, Yuna;
    • Koi, Satoshi;
    • Kimura, Takafumi;
    • Ichinohe, Tatsuo;
    • Atsuta, Yoshiko;
    • Kanda, Junya
    Publication type:
    Article
    9
    10
    11

    Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 254, doi. 10.1002/ajh.27169
    By:
    • Gurnari, Carmelo;
    • Pascale, Maria Rosaria;
    • Vitale, Antonio;
    • Diral, Elisa;
    • Tomelleri, Alessandro;
    • Galossi, Elisa;
    • Falconi, Giulia;
    • Bruno, Alessandro;
    • Crisafulli, Francesca;
    • Frassi, Micol;
    • Cattaneo, Chiara;
    • Bertoli, Diego;
    • Bernardi, Massimo;
    • Condorelli, Annalisa;
    • Morsia, Erika;
    • Poloni, Antonella;
    • Crisà, Elena;
    • Caravelli, Daniela;
    • Triggianese, Paola;
    • Brussino, Luisa
    Publication type:
    Article
    12
    13

    Dosage of high‐dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E46, doi. 10.1002/ajh.27167
    By:
    • Wilson, Matthew R.;
    • Kirkwood, Amy A.;
    • Wong Doo, Nicole;
    • Soussain, Carole;
    • Choquet, Sylvain;
    • Lees, Charlotte;
    • Fox, Christopher;
    • Preston, Gavin;
    • Ahearne, Matthew;
    • Strüßmann, Tim;
    • Clavert, Aline;
    • Rusconi, Chiara;
    • Ku, Matthew;
    • Khwaja, Jahanzaib;
    • Narkhede, Mayur;
    • Lewis, Katharine;
    • Durot, Eric;
    • Smith, Jeffery;
    • Renaud, Loic;
    • Ferreri, Andrés J. M.
    Publication type:
    Article
    14
    15

    Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
    By:
    • Brunner, Andrew M.;
    • Esteve, Jordi;
    • Porkka, Kimmo;
    • Knapper, Steve;
    • Traer, Elie;
    • Scholl, Sebastian;
    • Garcia‐Manero, Guillermo;
    • Vey, Norbert;
    • Wermke, Martin;
    • Janssen, Jeroen J. W. M.;
    • Narayan, Rupa;
    • Fleming, Shaun;
    • Loo, Sun;
    • Tovar, Natalia;
    • Kontro, Mika;
    • Ottmann, Oliver G.;
    • Naidu, Purushotham;
    • Sun, Haiying;
    • Han, May;
    • White, Roisin
    Publication type:
    Article
    16

    Hematopoietic stem cell transplantation from haploidentical offspring donors using post‐transplant cyclophosphamide versus human leukocyte antigen‐matched siblings in older patients with myelodysplastic syndrome.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E42, doi. 10.1002/ajh.27160
    By:
    • Shimomura, Yoshimitsu;
    • Kitamura, Tetsuhisa;
    • Konuma, Takaaki;
    • Nakaya, Yosuke;
    • Doki, Noriko;
    • Sawa, Masashi;
    • Nakamae, Hirohisa;
    • Eto, Tetsuya;
    • Nishida, Tetsuya;
    • Ohigashi, Hiroyuki;
    • Ota, Shuichi;
    • Onizuka, Makoto;
    • Hiramoto, Nobuhiro;
    • Kawakita, Toshiro;
    • Kanda, Junya;
    • Ichinohe, Tatsuo;
    • Atsuta, Yoshiko;
    • Itonaga, Hidehiro
    Publication type:
    Article
    17

    Elevated MCHC reveals a Southeast Asian Ovalocytosis.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 331, doi. 10.1002/ajh.27157
    By:
    • Souissi, Maïssa;
    • Daliphard, Sylvie;
    • Picard, Véronique;
    • Lebigot, Elise;
    • Jardin, Fabrice;
    • Bobée, Victor
    Publication type:
    Article
    18
    19
    20

    Retention of uninfected red blood cells causing congestive splenomegaly is the major mechanism of anemia in malaria.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 223, doi. 10.1002/ajh.27152
    By:
    • Kho, Steven;
    • Siregar, Nurjati C.;
    • Qotrunnada, Labibah;
    • Fricot, Aurélie;
    • Sissoko, Abdoulaye;
    • Shanti, Putu A. I.;
    • Candrawati, Freis;
    • Kambuaya, Noy N.;
    • Rini, Hasrini;
    • Andries, Benediktus;
    • Hardy, David;
    • Margyaningsih, Nur I.;
    • Fadllan, Fauziyah;
    • Rahmayenti, Desandra A.;
    • Puspitasari, Agatha M.;
    • Aisah, Amelia R.;
    • Leonardo, Leo;
    • Yayang, Bagus T. G.;
    • Margayani, Dewi S.;
    • Prayoga, Pak
    Publication type:
    Article
    21
    22

    Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 203, doi. 10.1002/ajh.27150
    By:
    • Rovó, Alicia;
    • Gras, Luuk;
    • Piepenbroek, Brian;
    • Kröger, Nicolaus;
    • Reinhardt, H. Christian;
    • Radujkovic, Aleksandar;
    • Blaise, Didier;
    • Kobbe, Guido;
    • Niityvuopio, Riitta;
    • Platzbecker, Uwe;
    • Sockel, Katja;
    • Hunault‐Berger, Mathilde;
    • Cornelissen, J. J.;
    • Forcade, Edouard;
    • Bourhis, Jean Henri;
    • Chalandon, Yves;
    • Kinsella, Francesca;
    • Nguyen‐Quoc, Stéphanie;
    • Maertens, Johan;
    • Elmaagacli, Ahmet
    Publication type:
    Article
    23

    Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
    By:
    • Gangat, Naseema;
    • Karrar, Omer;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Abdallah, Mostafa;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Issue Information.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 147, doi. 10.1002/ajh.26972
    Publication type:
    Article
    30
    31